Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

iBio Inc. sell geldnutzer

Start price
€111.50
25.07.20 / 50%
Target price
€50.00
13.08.20
Performance (%)
-49.33%
End price
€56.50
13.08.20
Summary
This prediction ended on 13.08.20 with a price of €56.50. The SELL prediction by geldnutzer for iBio Inc. performed very well with a performance of -49.33%. geldnutzer has a follow-up prediction for iBio Inc. where he still thinks iBio Inc. is a Sell. geldnutzer has 50% into this prediction

iBio is a listed biotechnology company with the ticker symbol iBio that focuses on developing novel plant-based biologics and vaccines to combat infectious diseases and other medical conditions. The company leverages its proprietary expression technology to rapidly produce high-quality proteins at a commercial scale, providing a cost-effective and scalable alternative to traditional manufacturing processes. iBio has strategic collaborations with leading pharmaceutical companies and is actively exploring partnerships to advance its product pipeline and expand its reach. The company is headquartered in Bryan, Texas, and is publicly traded on the NYSE American stock exchange.

Performance without dividends (%)
Name 1w 1m 1y 3y
iBio Inc. - - - -
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to geldnutzer what are the pros and cons of iBio Inc. for the foreseeable future?

Pros
Capable Management
Good culture
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Innovative
Sustainability is important
Medium risks for its business
Known brand
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Good rating
Standard Investments for future growth
Some uniques
Growths faster than the competition
Top 10 in its market
Future proof or reliable business model
Cons
Dependend from some customers or products
Significant cyclical dependencies
Very low/no dividend yield expected
Revenue decline/stagnation expected

Comments by geldnutzer for this prediction

In the thread iBio Inc. diskutieren
Prediction Sell
Perf. (%) -49.33%
Target price 3.000
Change
Ends at 13.08.20

Sell mit Kursziel 3,0

Prediction Sell
Perf. (%) -49.33%
Target price 2.000
Change
Ends at 13.08.20

Kursziel geändert auf 2,0

In the thread Trading iBio Inc.
Prediction Sell
Perf. (%) -49.33%
Target price 2.000
Change
Ends at 13.08.20

Sell beendet

Current prediction by geldnutzer for iBio Inc.

iBio Inc.

Start price
Target price
Perf. (%)
€0.99
26.04.23
€0.20
26.04.24
-81.42%
28.11.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products

Stopped prediction by geldnutzer for iBio Inc.

buy
iBio Inc.

Start price
Target price
Perf. (%)
€1.18
27.02.23
€1.10
27.02.24
-16.47%
26.04.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
iBio Inc.

Start price
Target price
Perf. (%)
€1.50
13.10.22
€0.10
13.10.23
-21.39%
27.02.23

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
iBio Inc.

Start price
Target price
Perf. (%)
€6.24
03.08.22
€5.00
03.08.23
-75.96%
13.10.22

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
iBio Inc.

Start price
Target price
Perf. (%)
€15.25
05.12.21
€5.00
05.12.22
-59.08%
03.08.22

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
iBio Inc.

Start price
Target price
Perf. (%)
€17.28
02.11.21
€22.50
02.11.22
-11.72%
05.12.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
iBio Inc.

Start price
Target price
Perf. (%)
€16.58
01.11.21
€12.50
01.11.22
4.19%
02.11.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
iBio Inc.

Start price
Target price
Perf. (%)
€30.56
28.05.21
€25.00
28.05.22
-45.75%
01.11.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
iBio Inc.

Start price
Target price
Perf. (%)
€33.50
06.05.21
€25.00
06.05.22
-8.77%
28.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
iBio Inc.

Start price
Target price
Perf. (%)
€41.75
20.02.21
€27.50
20.02.22
-19.76%
06.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
iBio Inc.

Start price
Target price
Perf. (%)
€54.00
15.08.20
€17.50
04.11.21
-22.69%
20.02.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
iBio Inc.

Start price
Target price
Perf. (%)
€56.50
13.08.20
€62.50
15.08.20
-4.42%
15.08.20

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products